CH555852A - Verfahren zur herstellung von gegen trypanosomiasis wirksamen, substituierten nitroimidazolen. - Google Patents

Verfahren zur herstellung von gegen trypanosomiasis wirksamen, substituierten nitroimidazolen.

Info

Publication number
CH555852A
CH555852A CH21171A CH21171A CH555852A CH 555852 A CH555852 A CH 555852A CH 21171 A CH21171 A CH 21171A CH 21171 A CH21171 A CH 21171A CH 555852 A CH555852 A CH 555852A
Authority
CH
Switzerland
Prior art keywords
production
effective against
nitroimidazoles
substituted
against trypanosomiasis
Prior art date
Application number
CH21171A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH555852A publication Critical patent/CH555852A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH21171A 1970-01-07 1971-01-07 Verfahren zur herstellung von gegen trypanosomiasis wirksamen, substituierten nitroimidazolen. CH555852A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US130770A 1970-01-07 1970-01-07

Publications (1)

Publication Number Publication Date
CH555852A true CH555852A (de) 1974-11-15

Family

ID=21695371

Family Applications (1)

Application Number Title Priority Date Filing Date
CH21171A CH555852A (de) 1970-01-07 1971-01-07 Verfahren zur herstellung von gegen trypanosomiasis wirksamen, substituierten nitroimidazolen.

Country Status (11)

Country Link
US (1) US3711495A (de)
JP (1) JPS511717B1 (de)
CA (1) CA988089A (de)
CH (1) CH555852A (de)
DE (1) DE2100242C2 (de)
FR (1) FR2081416B1 (de)
GB (1) GB1316221A (de)
NL (1) NL7018072A (de)
OA (1) OA03554A (de)
ZA (1) ZA707997B (de)
ZM (1) ZM14570A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915978A (en) * 1970-01-07 1975-10-28 Merck & Co Inc Nitroimidazoles
DE2229248C3 (de) * 1971-07-30 1980-03-27 Gruppo Lepetit S.P.A., Mailand (Italien) 5-Iminomethyl-2-nitroimidazoI-Derivate und Verfahren zu deren Herstellung
US4010176A (en) * 1972-10-27 1977-03-01 Merck & Co., Inc. Isoxazole substituted nitroimidazoles
US4080340A (en) * 1975-07-30 1978-03-21 Merck & Co., Inc. Nitroimidazoles
DE2613167A1 (de) * 1976-03-27 1977-10-06 Bayer Ag Oximcarbamate, verfahren zu ihrer herstellung und ihre verwendung als insektizide, akarizide und nematozide
US4268674A (en) * 1977-11-14 1981-05-19 The Dow Chemical Company Preparation of substituted oxatriazoles
US4144345A (en) * 1977-11-30 1979-03-13 Merck & Co., Inc. Dihydroxybenzisoxazolin-3-yl-substituted-5-nitroimidazoles as antibacterials and antiprotozoals
EP0002344B1 (de) * 1977-11-30 1982-09-15 Merck & Co. Inc. Substituierte Nitroimidazole, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen
US4269830A (en) * 1979-05-17 1981-05-26 Merck & Co., Inc. Compositions and methods for the treatment of chronic trypanosomiasis infections
GB2101886B (en) * 1981-05-22 1985-07-31 Merck & Co Inc Compositions for the treatment of chronic trypanosomiasis infections
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US4767867A (en) * 1987-04-10 1988-08-30 Pennwalt Corporation 5-(alkoxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4727156A (en) * 1986-08-27 1988-02-23 Pennwalt Corporation 3-(Substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-{[(substituted phenyl)thio]me}isoxazolidine derivatives
US4769468A (en) * 1987-04-10 1988-09-06 Penwalt Corporation 5-(acyloxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4719306A (en) * 1986-08-27 1988-01-12 Pennwalt Corporation Substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4723021A (en) * 1986-08-27 1988-02-02 Pennwalt Corporation Substituted 5-(phenoxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4831154A (en) * 1987-04-10 1989-05-16 Pennwalt Corporation 5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4767866A (en) * 1987-04-10 1988-08-30 Pennwalt Corporation 3-Phenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5-alkylisoxazolidines
US4727157A (en) * 1986-08-27 1988-02-23 Pennwalt Corporation 3-(Substituted phenyl)-3-(1H-1,2,4-triazol-1-yl)methyl-2-methyl-5-[(substituted phenoxy)methyl]isoxazolidine derivatives
US4767868A (en) * 1987-04-10 1988-08-30 Pennwalt Corporation 3-Phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-[(phenylamino)methyl]isoxazolidines
US4769471A (en) * 1987-04-10 1988-09-06 Pennwalt Corporation Substituted 3,5-diphenyl-3-(1H-1,2,4-triazol-1-yl-methyl)-2-methylisoxazolidines
US4769469A (en) * 1987-04-10 1988-09-06 Pennwalt Corporation 5-(phenyl or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4769470A (en) * 1987-10-02 1988-09-06 Pennwalt Corporation 5-(phenyl or phenoxyalkyl)-3-(2-thienyl)-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4754042A (en) * 1987-10-02 1988-06-28 Pennwalt Corporation 5-{[naphthyl(or 2-oxo-1,3-benzoxathiol-6-yl)oxy]methyl}-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4777262A (en) * 1987-10-02 1988-10-11 Pennwalt Corporation 5-(substituted thiomethyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivatives
US4777263A (en) * 1987-10-02 1988-10-11 Pennwalt Corporation 5-substituted-3-(2-naphthalenyl)-3-((1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl))-2-methylisoxazolidines
US4785117A (en) * 1987-10-02 1988-11-15 Pennwalt Corporation 5,5-disubstituted-3-phenyl-3-phenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2-methylisoxazolidine derivatives (IR 3012)
US4749793A (en) * 1987-10-02 1988-06-07 Pennwalt Corporation 5-substituted-3-phenyl-3-[1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl]-2-benzylisoxazolidines (ir 3011)
US4777264A (en) * 1987-10-02 1988-10-11 Pennwalt Corporation 5-carbonyl derivatives of 3-phenyl-3-(1H-imadazol-1-ylmethyl)-2-methylisoxazolidines and related compounds thereof
US4835283A (en) * 1988-03-07 1989-05-30 Pennwalt Corporation 3,5-diphenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2
US6072057A (en) * 1996-06-06 2000-06-06 Gliatech Inc. 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents
US6329342B1 (en) 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
AU3180999A (en) * 1998-02-25 1999-09-15 Pharmacia & Upjohn Company Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) * 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
US7125840B2 (en) * 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
US20060167268A1 (en) * 2002-04-09 2006-07-27 Eli Lilly And Company, Patent Division, Growth hormone secretagogues
ES2271557T3 (es) * 2002-04-09 2007-04-16 Eli Lilly And Company Secretagogos dipeptidicos de la hormona del crecimiento.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1162257A (en) * 1965-09-22 1969-08-20 Danippon Pharmaceutical Co Ltd 3-(5-Nitro-2-Furyl) Isoxazole Derivatives and methods of preparation thereof
FR1510315A (fr) * 1966-02-03 1968-01-19 Ciba Geigy Procédé pour la préparation de 4-diaza-cyclo-alcano-pyrazoles substitués en position 1 par des restes hétérocycliques bicycliques
US3452035A (en) * 1966-12-23 1969-06-24 American Cyanamid Co 2 - amino - 5 - (5 - nitro - 1 - substituted-2 - imidazolyl) - 1,3,4 - thiadiazoles and oxadiazoles

Also Published As

Publication number Publication date
FR2081416A1 (de) 1971-12-03
OA03554A (fr) 1971-03-30
US3711495A (en) 1973-01-16
DE2100242A1 (de) 1971-07-15
FR2081416B1 (de) 1974-09-27
CA988089A (en) 1976-04-27
ZA707997B (en) 1972-07-26
GB1316221A (en) 1973-05-09
NL7018072A (de) 1971-07-09
ZM14570A1 (en) 1972-08-21
DE2100242C2 (de) 1984-07-19
JPS511717B1 (de) 1976-01-20

Similar Documents

Publication Publication Date Title
CH555852A (de) Verfahren zur herstellung von gegen trypanosomiasis wirksamen, substituierten nitroimidazolen.
CH557844A (de) Verfahren zur herstellung von styrol-acrylnitril-copolymeren.
CH550771A (de) Verfahren zur herstellung von phenaethylaminderivaten.
CH557350A (de) Verfahren zur herstellung von sulfonierten phthalimidinen.
CH554858A (de) Verfahren zur herstellung von methyl-n-acetal-6,7-aziridino-6-desamino-7-desoxy-(alpha)-thiolincosamidinen.
CH550133A (de) Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat.
CH550214A (de) Verfahren zur herstellung von cyclocopolymerisaten.
CH558802A (de) Verfahren zur herstellung von imidazolen.
CH557365A (de) Verfahren zur herstellung von 5-amino-substituierten imidazolen.
CH550797A (de) Verfahren zur herstellung von tetrahydroisochinolinderivaten.
CH557830A (de) Verfahren zur herstellung von 1-aminosiochinolinen.
CH558800A (de) Verfahren zur herstellung von chinazolinonen.
CH549567A (de) Verfahren zur herstellung von 8-cyano-5-octanolid.
CH547775A (de) Verfahren zur herstellung von diaethylaminopropionaniliden.
CH553185A (de) Verfahren zur herstellung von lumilysergol-derivaten.
CH558809A (de) Verfahren zur herstellung von penicillinen.
CH553242A (de) Verfahren zur herstellung von fluoreszierenden verbindungen.
CH550809A (de) Verfahren zur herstellung von triazol-derivaten.
CH557796A (de) Verfahren zur herstellung von cyclopropylmethylalkylaminen.
CH547802A (de) Verfahren zur herstellung von tetrahydropyridinderivaten.
CH548398A (de) Verfahren zur herstellung von substituierten imidazolen.
CH546211A (de) Verfahren zur herstellung von fluorjodalkanen.
CH555850A (de) Verfahren zur herstellung von 3-aryl-benzazinen.
CH548351A (de) Verfahren zur herstellung von 3-alkyl-5-tert.-butylphenolen.
CH557370A (de) Verfahren zur herstellung von isoxazolylaethyl-tetrahydropyranolen.

Legal Events

Date Code Title Description
PL Patent ceased